Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta L Capone

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|February 4, 2003
Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitorPaola Patrignani, Marta L Capone, Stefania Tacconelli
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Clinical pharmacology of etoricoxibMarta L Capone, Stefania Tacconelli, Paola Patrignani
Heart (British Cardiac Society)|March 19, 2008
NSAIDs and cardiovascular diseasePaola Patrignani, Marta L Capone, Stefania Tacconelli
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidationStefania Tacconelli, Marta L Capone, Paola Patrignani
Therapeutics and Clinical Risk Management|February 12, 2009
Risk management profile of etoricoxib: an example of personalized medicinePaola Patrignani, Stefania Tacconelli, Marta L Capone
Pharmacological Reports : PR|July 16, 2010
NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general populationMarta L Capone, Stefania Tacconelli, Luis Garcia Rodriguez, et al.
Brain Research. Brain Research Reviews|April 27, 2005
New insights into COX-2 biology and inhibitionPaola Patrignani, Stefania Tacconelli, Maria Gina Sciulli, et al.
Pharmacological Reports : PR|January 18, 2006
The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and painMaria G Sciulli, Marta L Capone, Stefania Tacconelli, et al.
Current Medical Research and Opinion|February 5, 2003
The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activityStefania Tacconelli, Marta L Capone, Maria G Sciulli, et al.
Expert Opinion on Drug Safety|January 4, 2008
Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outsMarta L Capone, Stefania Tacconelli, Luigia Di Francesco, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|February 4, 2003
Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitorPaola Patrignani, Marta L Capone, Stefania Tacconelli
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Clinical pharmacology of etoricoxibMarta L Capone, Stefania Tacconelli, Paola Patrignani
Heart (British Cardiac Society)|March 19, 2008
NSAIDs and cardiovascular diseasePaola Patrignani, Marta L Capone, Stefania Tacconelli
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidationStefania Tacconelli, Marta L Capone, Paola Patrignani
Therapeutics and Clinical Risk Management|February 12, 2009
Risk management profile of etoricoxib: an example of personalized medicinePaola Patrignani, Stefania Tacconelli, Marta L Capone
Pharmacological Reports : PR|July 16, 2010
NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general populationMarta L Capone, Stefania Tacconelli, Luis Garcia Rodriguez, et al.
Brain Research. Brain Research Reviews|April 27, 2005
New insights into COX-2 biology and inhibitionPaola Patrignani, Stefania Tacconelli, Maria Gina Sciulli, et al.
Pharmacological Reports : PR|January 18, 2006
The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and painMaria G Sciulli, Marta L Capone, Stefania Tacconelli, et al.
Current Medical Research and Opinion|February 5, 2003
The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activityStefania Tacconelli, Marta L Capone, Maria G Sciulli, et al.
Expert Opinion on Drug Safety|January 4, 2008
Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outsMarta L Capone, Stefania Tacconelli, Luigia Di Francesco, et al.
Pageof 3